Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) is now available.
The Hydration Pharmaceuticals Company Limited has reported a change in director Adem Karafili’s relevant interests following the expiry and cancellation of 500,000 unlisted options held indirectly through Ankara Holdings Pty Ltd as trustee structures he controls. After the expiry-driven cancellation, Karafili’s indirect holdings remain substantial, comprising 2,562,389 fully paid ordinary shares and a suite of unlisted options with varying exercise prices and maturities through 2029, signalling a modest simplification of his equity-linked incentives without altering his underlying shareholding base.
The most recent analyst rating on (AU:HPC) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Hydration Pharmaceuticals Co. Ltd. stock, see the AU:HPC Stock Forecast page.
More about Hydration Pharmaceuticals Co. Ltd.
The Hydration Pharmaceuticals Company Limited is an Australia-listed company; the filing does not specify its industry, products or services, or target markets.
Average Trading Volume: 4,803,902
Technical Sentiment Signal: Sell
Current Market Cap: A$2.15M
Learn more about HPC stock on TipRanks’ Stock Analysis page.